Skip to content

The BRIDGE Rehabilitation Trial

The BRIDGE Trial: A Multicenter RCT to Improve Continuity and Quality in Rehabilitation of People With Rheumatic and Musculoskeletal Diseases

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03102814
Acronym
BRIDGE
Enrollment
381
Registered
2017-04-06
Start date
2017-08-15
Completion date
2019-08-30
Last updated
2020-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Musculoskeletal Disease

Brief summary

The main aim of this multi-centre stepped wedge randomized controlled trial is to improve the quality, professional practice and cost-effective utilization of health care resources by evaluating if a new rehabilitation program aimed at bridging gaps in rehabilitation across levels of care may increase and/or prolong the effect of rehabilitation.

Detailed description

The goal of rehabilitation is to help people to reach and maintain their optimal functioning and coping capabilities, and to promote independence and participation in society. According to current political documents, there are large variation in the content and quality of rehabilitation in Norway, and systems to improve coordination and communication are needed. This trial is a collaborative project between eight centres across Norway, investigating whether a new program aimed at bridging gaps in rehabilitation across levels of care increase and/or prolong the effect of rehabilitation for people with rheumatic and musculoskeletal diseases. Additionally, we will use a newly developed set of quality indicators to monitor and compare the quality of rehabilitation across different centres, and explore relationships between adherence to structure and process indicators and the outcomes of rehabilitation. The effects will be evaluated in a multi-centre stepped wedge randomized controlled trial, where participating centres switch from control (current rehabilitation program) to intervention phase (adding the BRIDGE program to the current program) in a randomized order. Primary outcome is goal attainment after seven months, and secondary outcomes are health related quality of life and function. The results will give insight in the content and organisation of current rehabilitation programs, what follow-up people want and receive in primary care, their planned and completed efforts to implement and maintain life style changes, and predictors for improvement following rehabilitation in specialist health care. Results will also have consequences on how rehabilitation is to be organized in the future regarding follow-up and coordination across levels of care. The study has been developed in close collaboration with patient research partners, clinicians and international experts, who will also contribute in the process of integrating study results in clinical practice.

Interventions

BEHAVIORALCurrent rehabilitation

The control group will receive the rehabilitation currently offered at each of the participating centers.

BEHAVIORALThe BRIDGE program

The experimental group will additionally receive the BRIDGE program, which comprises motivational interviewing, structured goal-setting, tailored follow-up, plans for self-management, and individualised written feedback that participants can use to monitor their progress and share with important care givers.

Sponsors

Sørlandet Hospital
CollaboratorUNKNOWN
Vikersund Rehabilitation Centre
CollaboratorUNKNOWN
Muritunet Rehabilitation Centre
CollaboratorUNKNOWN
Valnesfjord Rehabilitation Centre
CollaboratorUNKNOWN
Meråker Rehabilitation Centre
CollaboratorUNKNOWN
Rehab Vest Rehabilitation Centre
CollaboratorUNKNOWN
Lillehammer Rheumatism Hospital
CollaboratorUNKNOWN
Haugesund Rheumatism Hospital
CollaboratorOTHER
National Resource Center for Rehabilitation in Rheumatology
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Masking description

Due to the nature of the study intervention, it is not possible to blind participants or the health care providers. However, the statistician who will perform the main statistical analyses will be blinded to group allocation.

Intervention model description

In order to evaluate the effects of the BRIDGE program, a stepped wedge cluster randomized controlled trial will be conducted. In the trial, participating centres switch from control (current rehabilitation program) to intervention phase (adding the BRIDGE program to the current program) in a randomized order. All centres start the trial simultaneously and act as controls until the point in time they are randomized to crossover from control to intervention, and all centres deliver the intervention by the end of inclusion. The stepped wedge design is suitable for a phased evaluation approach, where it is difficult to deliver two parallel interventions.

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* inflammatory rheumatic disease or osteoarthritis or fibromyalgia or low back pain or wide spread pain or osteoporosis. Having a good understanding of Norwegian and having a bank-ID

Exclusion criteria

* Cognitive impairment or severe psychiatric disorder

Design outcomes

Primary

MeasureTime frameDescription
Goal attainment measured by the Patient Specific Functional ScaleOne yearGoal attainment will be measured by the Patient Specific Functional Scale

Secondary

MeasureTime frameDescription
Health-related quality of life measured by the EQ5DOne yearHealth-related quality of life will be measured by the EQ5D
Physical function measured by the 30 sec sit to stand testOne yearPhysical function will be measured by the 30 sec sit to stand test

Other

MeasureTime frameDescription
Function in daily activities measured by the Hannover Functional Ability QuestionnaireOne yearDaily activities will be measured by the Hannover Functional Ability Questionnaire
Coping measured by the Effective Musculoskeletal Consumer ScaleOne yearCoping will be measured by the Effective Musculoskeletal Consumer Scale
Pain measured on a numeric rating scaleOne yearPain will be measured on a numeric rating scale
Participation measured by participation scale in COOP/WONCAOne yearParticipation will be measured by participation scale in COOP/WONCA
Mental health measured by the Hopkins Symptom ChecklistOne yearMental health will be measured by the Hopkins Symptom Checklist
Fatigue measured on a numeric rating scaleOne YearFatigue will be measured on a numeric rating scale
Motivation for goal attainment measured on a numeric rating scaleBaselineMotivation for goal attainment will be measured on a numeric rating scale

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 23, 2026